Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
July 31, 2026 0.00%
April 30, 2026 0.00%
January 31, 2026 0.00%
October 31, 2025 0.00%
July 31, 2025 0.00%
April 30, 2025 0.00%
January 31, 2025 0.00%
October 31, 2024 0.00%
July 31, 2024 0.00%
April 30, 2024 0.00%
October 31, 2023 -2.96%
July 31, 2023 -4.26%
April 30, 2023 0.00%
October 31, 2022 -23.82%
July 31, 2022 -55.24%
April 30, 2022 23.73%
October 31, 2021 50.99%
Date Value
July 31, 2021 12.98%
April 30, 2021 36.02%
January 31, 2021 21.83%
October 31, 2020 25.97%
July 31, 2020 25.07%
April 30, 2020 31.95%
January 31, 2020 21.84%
October 31, 2014
July 31, 2014
January 31, 2014
October 31, 2013
July 31, 2013
April 30, 2013
January 31, 2013 0.00%
March 31, 1999 0.00%
December 31, 1998 0.00%
September 30, 1998 0.00%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Xcelerate, Inc. --
Vivos Therapeutics, Inc. 47.41%
Hinge Health, Inc. 86.44%
Anika Therapeutics, Inc. 65.15%
Enovis Corp. 54.51%

Gross Profit Margin (Quarterly) Related Metrics